Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents

Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents

Abstract Background Immunoglobulin G4-related sialadenitis (IgG4-RS) is a newly recognized immune-mediated systemic disease. Despite its good response to steroid therapy, its treatment protocol is not standardized and the long-term outcome is controversial. The study was conducted to determine the s...

Full description

Bibliographic Details
Main Authors: Xia Hong, Yan-Yan Zhang, Wei Li, Yan-Ying Liu, Zhen Wang, Yan Chen, Yan Gao, Zhi-Peng Sun, Xin Peng, Jia-Zeng Su, Zhi-Gang Cai, Lei Zhang, Jing He, Li-Min Ren, Hong-Yu Yang, Zhan-Guo Li, Guang-Yan Yu
Format: Article
Language:English
Published: BMC 2018-01-01
Series:Arthritis Research & Therapy
Subjects:
IgG4-related sialadenitis
Treatment
Glucocorticoid
Steroid-sparing agents
Serum IgG4 level
Online Access:http://link.springer.com/article/10.1186/s13075-017-1507-6

Internet

http://link.springer.com/article/10.1186/s13075-017-1507-6

Similar Items